Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
暂无分享,去创建一个
M. Dimopoulos | K. Koutsoukos | M. Liontos | F. Zagouri | D. Tiniakos | A. Kyriazoglou | E. Dimitriadis
[1] Robin L. Jones,et al. ANNOUNCE: A randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox) + olaratumab versus dox + PBO in patients (pts) with advanced soft tissue sarcomas (STS). , 2019, Journal of Clinical Oncology.
[2] M. Dimopoulos,et al. Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning? , 2019, ESMO Open.
[3] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[4] S. Sleijfer,et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[5] G. Weinberg,et al. Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma , 2018, Cancers.
[6] P. Chu,et al. Primary liver sarcomas in the modern era: Resection or transplantation? , 2018, Journal of surgical oncology.
[7] G. Gores,et al. Platelet‐derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation , 2018, Journal of cellular biochemistry.
[8] M. McCarter,et al. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[9] Jun Zhang,et al. Apatinib for the treatment of pulmonary epithelioid hemangioendothelioma , 2017, Medicine.
[10] V. Liska,et al. Hepatic Epithelioid Hemangioendothelioma - a Rare Tumor and Diagnostic Dilemma. , 2017, In vivo.
[11] M. Afrit,et al. Aggressive primary hepatic epithelioid hemangioendothelioma: a case report and literature review , 2017, Cancer biology & medicine.
[12] V. Mazzaferro,et al. Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry , 2017, Transplantation.
[13] Robin L. Jones,et al. Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis , 2017, Acta oncologica.
[14] Seung‐Mo Hong,et al. Clinicopathological Features and Prognosis of Hepatic Epithelioid Hemangioendothelioma After Liver Resection and Transplantation. , 2016, Annals of transplantation.
[15] Robin L. Jones,et al. Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial , 2016, The Lancet.
[16] F. Grosso,et al. Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database , 2016, Annals of Surgical Oncology.
[17] W. Yang,et al. Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements , 2016, Oncotarget.
[18] M. Wachtel,et al. Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine , 2015, Case reports in gastrointestinal medicine.
[19] Z. Keidar,et al. Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma—a suitable treatment option: case report and review of anti-angiogenic treatment options , 2015, BMC Cancer.
[20] Wei Zhang,et al. Hepatic epithelioid hemangioendothelioma metastasized to the peritoneum, omentum and mesentery: a case report. , 2015, International journal of clinical and experimental pathology.
[21] C. Fisher,et al. Systemic treatment options for epithelioid haemangioendothelioma: the Royal Marsden Hospital experience. , 2015, Anticancer research.
[22] K. Dudek,et al. Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation. , 2014, World journal of gastroenterology.
[23] S. Curley,et al. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[24] J. V. van Gorp,et al. Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases , 2014, Diagnostic Pathology.
[25] S. Pileri,et al. Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma. , 2014, World journal of gastroenterology.
[26] Xaralabos Varelas,et al. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease , 2014, Development.
[27] J. Gugenheim,et al. Metastatic Hepatic Epithelioid Hemangio-Endothelioma: Long-Term Response to Sunitinib Malate , 2014, Oncology Research and Treatment.
[28] J. Blay,et al. Sorafenib in patients with progressive epithelioid hemangioendothelioma , 2013, Cancer.
[29] C. Borg,et al. Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendothelioma. , 2013, Journal of Hepatology.
[30] D. Indelicato. F1000Prime recommendation of Sorafenib in patients with progressive epithelioid hemangioendothelioma: a phase 2 study by the French Sarcoma Group (GSF/GETO). , 2013 .
[31] B. Han,et al. Treatment of pulmonary epithelioid hemangioendothelioma with combination chemotherapy: Report of three cases and review of the literature , 2013, Oncology letters.
[32] A. Dirican,et al. Malignant epithelioid hemangioendothelioma progressing after chemotherapy and Interferon treatment: a case presentation and a brief review of the literature. , 2013, Journal of cancer research and therapeutics.
[33] Vinod Ravi,et al. Vascular Sarcomas , 2013, Current Oncology Reports.
[34] M. von Mehren,et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[35] E. Lerut,et al. Epithelioid Hemangioendothelioma of the Kidney Treated with Sunitinib , 2012, Oncology Research and Treatment.
[36] K. Shetty,et al. Liver transplantation in the management of hepatic epithelioid hemangioendothelioma: a single-center experience and review of the literature. , 2011, Transplantation proceedings.
[37] M. Gerstein,et al. Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma , 2011, Science Translational Medicine.
[38] C. Antonescu,et al. A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites , 2011, Genes, chromosomes & cancer.
[39] V. Ravi,et al. Inhibiting the VEGF–VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor , 2010, Current opinion in oncology.
[40] M. Chung,et al. Pleural Epithelioid Hemangioendothelioma , 2008, Yonsei medical journal.
[41] B. O'Neil,et al. Response of epithelioid haemangioendothelioma to liposomal doxorubicin. , 2005, The Lancet. Oncology.
[42] D. V. van Thiel,et al. Successful medical treatment of an epithelioid hemangioendothelioma of liver. , 1997, Oncology.